743
Views
0
CrossRef citations to date
0
Altmetric
Review

A review of chronic wasting disease (CWD) spread, surveillance, and control in the United States captive cervid industry

ORCID Icon, , &
Pages 54-67 | Received 20 Sep 2023, Accepted 10 Apr 2024, Published online: 22 Apr 2024

Figures & data

Figure 1. Percent change in the number of captive cervids, by state, between 2002 and 2007, with states reporting cases of chronic wasting disease (CWD) in 2007 indicated with diagonal lines (adapted from Anderson and Chomphosy, 2014).

Figure 1. Percent change in the number of captive cervids, by state, between 2002 and 2007, with states reporting cases of chronic wasting disease (CWD) in 2007 indicated with diagonal lines (adapted from Anderson and Chomphosy, 2014).

Figure 2. Flowchart outlining literature screening process and outcomes.

Figure 2. Flowchart outlining literature screening process and outcomes.

Table 1. Peer-reviewed primary research articles addressing the spread, surveillance, and control of chronic wasting disease (CWD) in captive cervid facilities in the U.S. published as of November 2023.

Figure 3. Overview of chronic wasting disease (CWD) transmission routes to uninfected captive cervid herds.

Figure 3. Overview of chronic wasting disease (CWD) transmission routes to uninfected captive cervid herds.

Table 2. Qualitative risk assessment of chronic wasting disease (CWD) for captive cervid facilities in Minnesota and Wisconsin, USA, between 2002 and 2019 [Citation40].

Table 3. Risk levels of chronic wasting disease (CWD) experienced by captive cervid farms in Minnesota and Wisconsin, USA, between 2002 and 2019 [Citation40].

Figure 4. Contact networks between captive cervid farms in Pennsylvania, USA (Panel A), with the largest strongly connected component (139 farms) shown in blue (Panel B), between 2003 and 2011 [Citation38].

Figure 4. Contact networks between captive cervid farms in Pennsylvania, USA (Panel A), with the largest strongly connected component (139 farms) shown in blue (Panel B), between 2003 and 2011 [Citation38].

Figure 5. Timeline of chronic wasting disease (CWD) in North America and diagnostic test development.

Caption: Immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), western blot (WB), protein misfolding cyclic amplification (PMCA), and real-time quaking-induced conversion (RT-QuIC). States, provinces, and countries are indicated as follows: United States of America (orange), Canada (blue), and outside North America (yellow). Timeline adapted from Haley and Richt (2017), Hibler et al., 2003, CWD Alliance, and Rivera et al. (2019).
Figure 5. Timeline of chronic wasting disease (CWD) in North America and diagnostic test development.

Figure 6. Summary of identified risk factors based on their biological plausibility to spread CWD (adapted from EFSA 2019 [Citation49]).

Figure 6. Summary of identified risk factors based on their biological plausibility to spread CWD (adapted from EFSA 2019 [Citation49]).

Figure 7. National-level regulation for chronic wasting disease in the U.S., as of 2023.

Figure 7. National-level regulation for chronic wasting disease in the U.S., as of 2023.